Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aditya Sarawgi

Amgen’s Q4 2024 Earnings: What to Expect

Thousand Oaks, California-based Amgen Inc. (AMGN) discovers, develops, and manufactures innovative medicines aimed at improving the lives of millions. With a market cap of $142 billion, Amgen has been a pioneer in the biotechnology industry for over 40 years. Its portfolio includes treatments for cancer, heart disease, osteoporosis, inflammatory diseases, and rare conditions.

The drug manufacturer is expected to announce its fourth-quarter results on Tuesday, Feb. 4. Ahead of the event, analysts expect AMGN to report a non-GAAP profit of $5.02 per share, up 6.6% from $4.71 per share reported in the year-ago quarter. The company has a robust earnings surprise history. It has surpassed Wall Street’s bottom-line estimates in each of the past four quarters. Amgen’s adjusted EPS for the last reported quarter surged 12.5% year-over-year to $5.58, exceeding analysts’ estimates by 9.2%.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.